152 related articles for article (PubMed ID: 23601353)
1. Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs.
Smith LJ; Kukanich BK; Krugner-Higby LA; Schmidt BH; Heath TD
Vet Anaesth Analg; 2013 Sep; 40(5):537-45. PubMed ID: 23601353
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.
Smith LJ; KuKanich B; Hogan BK; Brown C; Heath TD; Krugner-Higby LA
J Vet Pharmacol Ther; 2008 Oct; 31(5):415-22. PubMed ID: 19000260
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques.
Krugner-Higby L; KuKanich B; Schmidt B; Heath TD; Brown C; Smith LJ
J Pharmacol Exp Ther; 2009 Jul; 330(1):135-41. PubMed ID: 19351868
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of hydromorphone hydrochloride in healthy dogs.
KuKanich B; Hogan BK; Krugner-Higby LA; Smith LJ
Vet Anaesth Analg; 2008 May; 35(3):256-64. PubMed ID: 18282253
[TBL] [Abstract][Full Text] [Related]
5. Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.
Smith LJ; Krugner-Higby L; Trepanier LA; Flaska DE; Joers V; Heath TD
J Vet Pharmacol Ther; 2004 Oct; 27(5):369-72. PubMed ID: 15500576
[No Abstract] [Full Text] [Related]
6. Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats.
Pypendop BH; Ilkiw JE; Shilo-Benjamini Y
J Vet Pharmacol Ther; 2014 Jun; 37(3):295-300. PubMed ID: 24236993
[TBL] [Abstract][Full Text] [Related]
7. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study.
Bateman SW; Haldane S; Stephens JA
Vet Anaesth Analg; 2008 Jul; 35(4):341-7. PubMed ID: 18363580
[TBL] [Abstract][Full Text] [Related]
9. Effect of morphine, methadone, hydromorphone or oxymorphone on the thermal threshold, following intravenous or buccal administration to cats.
Pypendop BH; Shilo-Benjamini Y; Ilkiw JE
Vet Anaesth Analg; 2016 Nov; 43(6):635-642. PubMed ID: 27723230
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
Sathyan G; Xu E; Thipphawong J; Gupta SK
BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study.
Adams MP; Ahdieh H
Pharmacotherapy; 2004 Apr; 24(4):468-76. PubMed ID: 15098800
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
[TBL] [Abstract][Full Text] [Related]
13. Effects of oxymorphone hydrochloride or hydromorphone hydrochloride on minimal alveolar concentration of desflurane in sheep.
Sayre RS; Lepiz MA; Horsley KT; Pashmakova MB; Barr JW; Washburn SE
Am J Vet Res; 2015 Jul; 76(7):583-90. PubMed ID: 26111087
[TBL] [Abstract][Full Text] [Related]
14. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of hydrocodone and hydromorphone after oral hydrocodone in healthy Greyhound dogs.
KuKanich B; Spade J
Vet J; 2013 May; 196(2):266-8. PubMed ID: 23098635
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment.
Durnin C; Hind ID; Wickens MM; Yates DB; Molz KH
Proc West Pharmacol Soc; 2001; 44():81-2. PubMed ID: 11794004
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in young and elderly subjects.
Durnin C; Hind ID; Ghani SP; Yates DB; Cross M
Proc West Pharmacol Soc; 2001; 44():79-80. PubMed ID: 11794003
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment.
Durnin C; Hind ID; Ghani SP; Yates DB; Molz KH
Proc West Pharmacol Soc; 2001; 44():83-4. PubMed ID: 11794005
[No Abstract] [Full Text] [Related]
19. Use of oral oxymorphone in the elderly.
Guay DR
Consult Pharm; 2007 May; 22(5):417-30. PubMed ID: 17658959
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oxymorphone in cats.
Siao KT; Pypendop BH; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2011 Dec; 34(6):594-8. PubMed ID: 21323677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
